Triple
T20694774
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Committee for Scientific and Technological Policy |
E508635
|
entity |
| Predicate | hasWorkingParty |
P128437
|
FINISHED |
| Object |
Working Party on Biotechnology, Nanotechnology and Converging Technologies
The Working Party on Biotechnology, Nanotechnology and Converging Technologies is an OECD expert group that advises on policy, governance, and responsible innovation related to emerging and converging science and technology fields.
|
E1445081
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Working Party on Biotechnology, Nanotechnology and Converging Technologies | Statement: [Committee for Scientific and Technological Policy, hasWorkingParty, Working Party on Biotechnology, Nanotechnology and Converging Technologies]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Working Party on Biotechnology, Nanotechnology and Converging Technologies Context triple: [Committee for Scientific and Technological Policy, hasWorkingParty, Working Party on Biotechnology, Nanotechnology and Converging Technologies]
-
A.
Working Party on Innovation and Technology Policy
The Working Party on Innovation and Technology Policy is an OECD expert group that advises on and develops international policies to foster innovation, technological development, and related economic growth.
-
B.
Subsidiary Body for Scientific and Technological Advice
The Subsidiary Body for Scientific and Technological Advice is a permanent UNFCCC body that provides governments with scientific, technical, and methodological guidance to inform international climate change negotiations and policy decisions.
-
C.
Subsidiary Body on Scientific, Technical and Technological Advice
The Subsidiary Body on Scientific, Technical and Technological Advice is a multidisciplinary expert body under the Convention on Biological Diversity that provides scientific and technical guidance to inform the treaty’s implementation and policy decisions.
-
D.
Committee for Scientific and Technological Policy
The Committee for Scientific and Technological Policy is an OECD body that guides international cooperation and policy-making on science, technology, and innovation among member countries.
-
E.
Committee for Advanced Therapies
The Committee for Advanced Therapies is a scientific body within the European Medicines Agency responsible for evaluating and providing expert opinions on advanced therapy medicinal products such as gene, cell, and tissue-engineered therapies.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Working Party on Biotechnology, Nanotechnology and Converging Technologies Triple: [Committee for Scientific and Technological Policy, hasWorkingParty, Working Party on Biotechnology, Nanotechnology and Converging Technologies]
Generated description
The Working Party on Biotechnology, Nanotechnology and Converging Technologies is an OECD expert group that advises on policy, governance, and responsible innovation related to emerging and converging science and technology fields.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Working Party on Biotechnology, Nanotechnology and Converging Technologies Target entity description: The Working Party on Biotechnology, Nanotechnology and Converging Technologies is an OECD expert group that advises on policy, governance, and responsible innovation related to emerging and converging science and technology fields.
-
A.
Working Party on Innovation and Technology Policy
The Working Party on Innovation and Technology Policy is an OECD expert group that advises on and develops international policies to foster innovation, technological development, and related economic growth.
-
B.
Subsidiary Body for Scientific and Technological Advice
The Subsidiary Body for Scientific and Technological Advice is a permanent UNFCCC body that provides governments with scientific, technical, and methodological guidance to inform international climate change negotiations and policy decisions.
-
C.
Subsidiary Body on Scientific, Technical and Technological Advice
The Subsidiary Body on Scientific, Technical and Technological Advice is a multidisciplinary expert body under the Convention on Biological Diversity that provides scientific and technical guidance to inform the treaty’s implementation and policy decisions.
-
D.
Committee for Scientific and Technological Policy
The Committee for Scientific and Technological Policy is an OECD body that guides international cooperation and policy-making on science, technology, and innovation among member countries.
-
E.
Committee for Advanced Therapies
The Committee for Advanced Therapies is a scientific body within the European Medicines Agency responsible for evaluating and providing expert opinions on advanced therapy medicinal products such as gene, cell, and tissue-engineered therapies.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69e0b4c2b2a481909e31e9cb8f81ab55 |
completed | April 16, 2026, 10:06 a.m. |
| NER | Named-entity recognition | batch_69e6c110c4108190a3ab171df33be194 |
completed | April 21, 2026, 12:13 a.m. |
| NED1 | Entity disambiguation (via context triple) | batch_6a08d7e6a5788190895d7becc9f8136b |
completed | May 16, 2026, 8:47 p.m. |
| NEDg | Description generation | batch_6a08d8e3b1d4819088fb2c3e54b7934e |
completed | May 16, 2026, 8:51 p.m. |
| NED2 | Entity disambiguation (via description) | batch_6a08d940f0e88190be17ae56546996af |
completed | May 16, 2026, 8:53 p.m. |
Created at: April 16, 2026, 12:10 p.m.